Skip to main content
. 2018 Oct 23;13(10):e0206246. doi: 10.1371/journal.pone.0206246

Fig 2. Anti-HER2 mAb production and purification.

Fig 2

(a) Fed-batch production in stirred-tank bioreactor. (b) The purification process of mAb.